Cellular Biomedicine Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CBMG and buy or sell other stocks, ETFs, and their options commission-free!About CBMG
AbelZeta Pharma, Inc. is a holding company, which engages in the development of treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy.
CEOBizuo Liu, MBA, CPA
CEOBizuo Liu, MBA, CPA
Employees—
Employees—
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2009
Founded2009
Employees—
Employees—
CBMG Key Statistics
Market cap384.15M
Market cap384.15M
Price-Earnings ratio-6.98
Price-Earnings ratio-6.98
Dividend yield—
Dividend yield—
Average volume168.23K
Average volume168.23K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$19.76
52 Week high$19.76
52 Week low$11.48
52 Week low$11.48
Stock Snapshot
With a market cap of 384.15M, Cellular Biomedicine Group(CBMG) trades at $19.75. The stock has a price-to-earnings ratio of -6.98.
During the trading day, Cellular Biomedicine Group(CBMG) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Cellular Biomedicine Group(CBMG) stock has reached 0, versus its average volume of 168.23K.
The stock's 52-week range extends from a low of $11.48 to a high of $19.76.
The stock's 52-week range extends from a low of $11.48 to a high of $19.76.
People also own
Based on the portfolios of people who own CBMG. This list is generated using Robinhood data, and it’s not a recommendation.